Atlas Trials

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Clinical trial NCT03020823 · TERMINATED

Trial details

NCT number
NCT03020823
Sponsor
SynCore Biotechnology Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Neoplasms
Start date
2017-04-30
Primary completion
2018-11-20
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.